NCT06857747 2025-03-04
Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Xi'an International Medical Center Hospital
The Netherlands Cancer Institute
Zhejiang Cancer Hospital
Zhejiang Cancer Hospital
Latin American & Caribbean Society of Medical Oncology
Peking Union Medical College Hospital
Zhejiang Cancer Hospital
Beijing Chao Yang Hospital
Hospital Authority, Hong Kong
Azienda Ospedaliera di Padova